236 related articles for article (PubMed ID: 3294051)
21. A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men.
Stone LM; Kahn SE; Fujimoto WY; Deeb SS; Porte D
Diabetes; 1996 Apr; 45(4):422-8. PubMed ID: 8603762
[TBL] [Abstract][Full Text] [Related]
22. [Application of hyperglycemic clamp technique in the assessment of beta-cell function in obese individuals with glucose intolerance].
Bao YQ; Jia WP; Zhu M; Lu JX; Chen L; Xiang KS
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1781-4. PubMed ID: 15631773
[TBL] [Abstract][Full Text] [Related]
23. The role of the splenic pancreatic lobe in regulating metabolic normalcy following 99% pancreatectomy in chickens.
Cieslak SR; Hazelwood RL
Gen Comp Endocrinol; 1986 Mar; 61(3):476-89. PubMed ID: 2870006
[TBL] [Abstract][Full Text] [Related]
24. Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.
Kahn SE; Verchere CB; Andrikopoulos S; Asberry PJ; Leonetti DL; Wahl PW; Boyko EJ; Schwartz RS; Newell-Morris L; Fujimoto WY
Diabetes; 1998 Apr; 47(4):640-5. PubMed ID: 9568698
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic polypeptide and other pancreatic hormones in spontaneously diabetic BB/W rats.
Tomita T; Doull V; Fredrickson D; Pollock G
Pancreas; 1990 Nov; 5(6):658-67. PubMed ID: 1980735
[TBL] [Abstract][Full Text] [Related]
26. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
[TBL] [Abstract][Full Text] [Related]
27. Effect of age on fasting plasma levels of pancreatic hormones in man.
Berger D; Crowther RC; Floyd JC; Pek S; Fajans SS
J Clin Endocrinol Metab; 1978 Dec; 47(6):1183-9. PubMed ID: 400740
[TBL] [Abstract][Full Text] [Related]
28. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
29. Impaired glucose tolerance in Thai adults: serum insulin profiles after a 75 gram oral glucose load.
Puavilai G; Tiewtranon V; Pensuwan S; Supitak V; Sriphrapradang A; Chanprasertyotin S
J Med Assoc Thai; 1989 Sep; 72(9):498-505. PubMed ID: 2681497
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of somatostatin in regulating pancreatic splenic lobe hormone secretion following 99% pancreatectomy in adult chickens.
Cieslak SR; Hazelwood RL
Gen Comp Endocrinol; 1986 Aug; 63(2):284-94. PubMed ID: 2877920
[TBL] [Abstract][Full Text] [Related]
31. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L
J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
[TBL] [Abstract][Full Text] [Related]
32. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
[TBL] [Abstract][Full Text] [Related]
33. Diurnal profile of pancreatic polypeptide, pancreatic glucagon, gut glucagon and insulin in human morbid obesity.
Holst JJ; Schwartz TW; Lovgreen NA; Pedersen O; Beck-Nielsen H
Int J Obes; 1983; 7(6):529-38. PubMed ID: 6360922
[TBL] [Abstract][Full Text] [Related]
34. Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in man.
Ahrén B; Pettersson M; Uvnäs-Moberg K; Gutniak M; Efendic S
Diabetes Res Clin Pract; 1991 Sep; 13(3):153-61. PubMed ID: 1683622
[TBL] [Abstract][Full Text] [Related]
35. Human C-peptide in normal and diabetic subjects.
Heding LG; Rasmussen SM
Diabetologia; 1975 Jun; 11(3):201-6. PubMed ID: 1149953
[TBL] [Abstract][Full Text] [Related]
36. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis.
Holl RW; Heinze E; Wolf A; Rank M; Teller WM
Eur J Pediatr; 1995 May; 154(5):356-61. PubMed ID: 7641765
[TBL] [Abstract][Full Text] [Related]
37. Effects of rosglitazone on plasma adiponectin, insulin sensitivity, and insulin secretion in high-risk African Americans with impaired glucose tolerance test and type 2 diabetes.
Osei K; Gaillard T; Kaplow J; Bullock M; Schuster D
Metabolism; 2004 Dec; 53(12):1552-7. PubMed ID: 15562399
[TBL] [Abstract][Full Text] [Related]
38. Changes in plasma glucagon, pancreatic polypeptide and insulin during development of alloxan diabetes mellitus in dog.
Tasaka Y; Inoue Y; Matsumoto H; Hirata Y
Endocrinol Jpn; 1988 Jun; 35(3):399-404. PubMed ID: 3058465
[TBL] [Abstract][Full Text] [Related]
39. Influence of methionine-enkephalin analogue (FK-33-824) on the secretion of pancreatic hormones.
Sekiya K; Funakoshi A; Shinozaki H; Nawata H; Kato K; Ibayashi H
Gastroenterol Jpn; 1985 Jun; 20(3):252-9. PubMed ID: 2864301
[TBL] [Abstract][Full Text] [Related]
40. Studies of glucose intolerance in cirrhosis of the liver.
Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
